Levi & Korsinsky Picked To Lead Corcept Stock Drop Suit

By Dorothy Atkins (October 8, 2019, 7:59 PM EDT) -- A California federal judge on Monday appointed Levi & Korsinsky LLP to lead a proposed class action alleging Corcept Therapeutics Inc. hid that it bribed doctors to promote its mifepristone drug Korlym and engaged in other shady sales practices, causing its stock to plummet when the allegations came to light....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!